Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Adds Momentum, But Big Barriers To Device Tax Repeal Remain

This article was originally published in The Gray Sheet

Executive Summary

Killing the 2.3% excise tax on U.S. device sales before it takes effect in January would be a major victory for the industry, but with opposition from the Senate and White House, achieving repeal remains a steep climb at best.

You may also be interested in...

House Votes To Repeal Device Tax, Again

Congressional leaders have again voted to repeal the 2.3 percent medical device tax criticized by industry for stifling innovation and jobs, and sent it to the Senate for approval. Concerns still surround whether the bill is approvable without an offset.

Device Tax Repeal Gains High Profile During Shutdown, But Significant Barriers Remain

Some House Democrats and Republicans are circulating a device tax repeal proposal, including an idea for replacing the revenue, to resolve the shutdown. But the president and Democratic leaders in the Senate insist that they will only accept a clean funding bill with no Obamacare strings attached.

News In Brief

New device tax repeal bills; 2012 VC funding data; more news.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts